Ms. Sarah Li - 16 Dec 2022 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role
VP Accounting & Controller
Signature
/s/ Eric A Adams, attorney-in-fact for Ms. Sarah Li
Issuer symbol
INM
Transactions as of
16 Dec 2022
Net transactions value
$0
Form type
4
Filing time
19 Dec 2022, 16:03:37 UTC
Previous filing
29 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INM Employee Stock Option (Right to Buy) Award $0 +3,600 +896% $0.000000 4,002 16 Dec 2022 Common shares 3,600 $1.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on 12/16/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant.